All Stories

  1. Convalescent Plasma does not improve in-hospital mortality among low SARS-CoV-2-IgG antibodies in COVID-19 hospitalized patients

    Article • September 2021, European Respiratory Society (ERS)

    Dr Marcos I. Restrepo

  2. Anti-Pseudomonas antibiotic use for hospitalized patients with community-acquired pneumonia

    Article • September 2020, European Respiratory Society (ERS)

    Dr Marcos I. Restrepo

  3. New perspectives in aspiration community acquired Pneumonia

    Article • Expert Review of Clinical Pharmacology, October 2019, Taylor & Francis

    Dr Marcos I. Restrepo, Abraham Rodriguez

  4. MRSA specific scores promote overuse of anti-MRSA antibiotics

    Article • September 2019, European Respiratory Society (ERS)

    Dr Marcos I. Restrepo

  5. Burden and risk factors forPseudomonas aeruginosacommunity-acquired pneumonia: a multinational point prevalence study of hospitalised patients

    Article • European Respiratory Journal, July 2018, European Respiratory Society (ERS)

    Dr Marcos I. Restrepo, Dr CATIA CILLONIZ, Dr Pedro J Marcos, Muhammad Irfan

  6. Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling

    Article • American Review of Respiratory Disease, September 2017, American Thoracic Society

    Dr Marcos I. Restrepo

  7. High endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis

    Article • European Respiratory Journal, July 2017, European Respiratory Society (ERS)

    Dr Marcos I. Restrepo, Dr Pedro J Marcos

  8. Managing community acquired pneumonia in the elderly – the next generation of pharmacotherapy on the horizon

    Article • Expert Opinion on Pharmacotherapy, June 2017, Taylor & Francis

    Dr Marcos I. Restrepo

  9. Year in review 2014: Interstitial lung disease, physiology, sleep and ventilation, acute respiratory distress syndrome, cystic fibrosis, bronchiectasis and rare lung disease

    Article • Respirology, March 2015, Wiley

    Toby Maher, Dr Marcos I. Restrepo

  10. Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia

    Article • Infection and Drug Resistance, February 2012, Taylor & Francis

    Dr Anoop M Nambiar, Dr Marcos I. Restrepo